As recently published, insulin and insulin-like growth factor-1 (IGF1) activates several pro-mitogenic and pro-angiogenic signaling mechanisms and thus support pathogenesis and the progression of several cancers, including breast cancers [51,52]. Here, IGF1 is linked to breast cancer.